These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26347495)

  • 1. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
    Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
    Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis.
    Liu H; Xu YB; Guo CC; Li MX; Ji JL; Dong RR; Zhang LL; He XX
    Cancer Med; 2019 Dec; 8(18):7577-7585. PubMed ID: 31657530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
    Ahn HK; Lee S; Park YH; Sohn JH; Jo JC; Ahn JH; Jung KH; Park S; Cho EY; Lee JI; Park W; Choi DH; Huh SJ; Ahn JS; Kim SB; Im YH
    Neuro Oncol; 2012 Aug; 14(8):1105-13. PubMed ID: 22693244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram.
    Pietrantonio F; Miceli R; Rimassa L; Lonardi S; Aprile G; Mennitto A; Marmorino F; Bozzarelli S; Antonuzzo L; Tamburini E; Morano F; Rossini D; Battaglin F; Baretti M; Berenato R; Formica V; Mosconi S; Petrelli F; Ghidini M; Loupakis F; Spada D; Cinieri S; Beretta G; Falcone A; de Braud F; Cremolini C
    Ann Oncol; 2017 Mar; 28(3):555-561. PubMed ID: 27864220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
    Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
    World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
    Li J; Gu J; Ma X; Li X; Liu X; Kang F; Xue F
    J Surg Oncol; 2018 Nov; 118(6):1034-1041. PubMed ID: 30196534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of colorectal cancer patients with brain metastases.
    Roussille P; Auvray M; Vansteene D; Lecomte T; Rigault E; Maillet M; Locher C; Dior M; Hautefeuille V; Artru P; Mabro M; Touchefeu Y; Marthey L; Moulin V; Louafi S; Lecaille C; Chautard R; Lièvre A; Zaanan A; Bennouna J; Berger A; Emambux S; Randrian V; Tougeron D
    Radiother Oncol; 2021 May; 158():67-73. PubMed ID: 33600872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
    Molitoris JK; Rao YJ; Patel RA; Kane LT; Badiyan SN; Gittleman H; Barnholtz-Sloan JS; Bentzen SM; Kruser TJ; Huang J; Mehta MP
    J Neurooncol; 2017 Sep; 134(2):331-338. PubMed ID: 28643151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicted survival in patients with brain metastases from colorectal cancer: Is a current nomogram helpful?
    Nieder C; Hintz M; Grosu AL
    Clin Neurol Neurosurg; 2016 Apr; 143():107-10. PubMed ID: 26914143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
    Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
    Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram for individualized estimation of survival among patients with brain metastasis.
    Barnholtz-Sloan JS; Yu C; Sloan AE; Vengoechea J; Wang M; Dignam JJ; Vogelbaum MA; Sperduto PW; Mehta MP; Machtay M; Kattan MW
    Neuro Oncol; 2012 Jul; 14(7):910-8. PubMed ID: 22544733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
    Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
    J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
    Marko NF; Xu Z; Gao T; Kattan MW; Weil RJ
    Cancer; 2012 Aug; 118(15):3749-57. PubMed ID: 22180078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
    Louie AV; Haasbeek CJ; Mokhles S; Rodrigues GB; Stephans KL; Lagerwaard FJ; Palma DA; Videtic GM; Warner A; Takkenberg JJ; Reddy CA; Maat AP; Woody NM; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):82-90. PubMed ID: 26138912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
    Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
    Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
    Prabhu RS; Press RH; Boselli DM; Miller KR; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Burri SH
    J Neurooncol; 2018 Mar; 137(1):147-154. PubMed ID: 29218431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.